Dai-ichi Life Insurance Company’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.05M | Buy |
3,645
+500
| +16% | +$321K | 0.06% | 247 |
|
|
2025
Q4 | $2.13M | Hold |
3,145
| – | – | 0.05% | 257 |
|
|
2025
Q3 | $2.01M | Sell |
3,145
-237
| -7% | -$144K | 0.05% | 271 |
|
|
2025
Q2 | $1.81M | Hold |
3,382
| – | – | 0.05% | 276 |
|
|
2025
Q1 | $1.42M | Hold |
3,382
| – | – | 0.04% | 316 |
|
|
2024
Q4 | $1.4M | Sell |
3,382
-2,675
| -44% | -$1.17M | 0.04% | 338 |
|
|
2024
Q3 | $3.06M | Sell |
6,057
-2,586
| -30% | -$1.26M | 0.08% | 219 |
|
|
2024
Q2 | $4.21M | Sell |
8,643
-3,730
| -30% | -$1.87M | 0.1% | 190 |
|
|
2024
Q1 | $6.68M | Buy |
12,373
+2,310
| +23% | +$1.26M | 0.15% | 134 |
|
|
2023
Q4 | $5.58M | Sell |
10,063
-3,224
| -24% | -$1.51M | 0.12% | 167 |
|
|
2023
Q3 | $5.81M | Sell |
13,287
-1,400
| -10% | -$698K | 0.13% | 151 |
|
|
2023
Q2 | $7.38M | Sell |
14,687
-10,964
| -43% | -$5.25M | 0.15% | 126 |
|
|
2023
Q1 | $12.8M | Sell |
25,651
-3,300
| -11% | -$1.58M | 0.28% | 75 |
|
|
2022
Q4 | $11.8M | Hold |
28,951
| – | – | 0.27% | 73 |
|
|
2022
Q3 | $9.43M | Sell |
28,951
-3,122
| -10% | -$1.15M | 0.23% | 88 |
|
|
2022
Q2 | $11.2M | Hold |
32,073
| – | – | 0.25% | 85 |
|
|
2022
Q1 | $17.5M | Buy |
32,073
+3,400
| +12% | +$1.79M | 0.28% | 84 |
|
|
2021
Q4 | $18.9M | Hold |
28,673
| – | – | 0.24% | 81 |
|
|
2021
Q3 | $17.8M | Sell |
28,673
-2,168
| -7% | -$1.46M | 0.23% | 85 |
|
|
2021
Q2 | $19.5M | Hold |
30,841
| – | – | 0.24% | 78 |
|
|
2021
Q1 | $15.1M | Hold |
30,841
| – | – | 0.21% | 87 |
|
|
2020
Q4 | $15.4M | Buy |
30,841
+4,900
| +19% | +$2.19M | 0.22% | 80 |
|
|
2020
Q3 | $10.2M | Sell |
25,941
-24
| -0.1% | -$8.87K | 0.18% | 103 |
|
|
2020
Q2 | $8.57M | Sell |
25,965
-247
| -0.9% | -$71.5K | 0.2% | 92 |
|
|
2020
Q1 | $6.35M | Buy |
26,212
+15,000
| +134% | +$3.91M | 0.24% | 99 |
|
|
2019
Q4 | $2.93M | Buy |
11,212
+169
| +2% | +$44.5K | 0.07% | 277 |
|
|
2019
Q3 | $3M | Sell |
11,043
-27,620
| -71% | -$7.69M | 0.07% | 261 |
|
|
2019
Q2 | $10.6M | Sell |
38,663
-60,675
| -61% | -$14.9M | 0.26% | 96 |
|
|
2019
Q1 | $22.2M | Buy |
99,338
+66,773
| +205% | +$13.8M | 0.55% | 37 |
|
|
2018
Q4 | $6.06M | Sell |
32,565
-15,023
| -32% | -$3.08M | 0.17% | 142 |
|
|
2018
Q3 | $11.9M | Buy |
47,588
+46,322
| +3,659% | +$11.2M | 0.26% | 98 |
|
|
2018
Q2 | $276K | Hold |
1,266
| – | – | 0.01% | 471 |
|
|
2018
Q1 | $242K | Buy |
+1,266
| New | +$234K | 0.01% | 474 |
|
|
2017
Q4 | – | Sell |
-32,206
| Closed | -$5.01M | – | 519 |
|
|
2017
Q3 | $5.01M | Buy |
32,206
+13,235
| +70% | +$2.09M | 0.11% | 187 |
|
|
2017
Q2 | $3.06M | Buy |
18,971
+12,201
| +180% | +$1.98M | 0.07% | 245 |
|
|
2017
Q1 | $1.05M | Buy |
6,770
+4,880
| +258% | +$673K | 0.03% | 379 |
|
|
2016
Q4 | $222K | Buy |
+1,890
| New | +$216K | 0.01% | 523 |
|
Other funds holding IDXX
VCM
VPM
Dai-ichi Life Insurance Company's IDXX Position: Q1 2026 in Review
Dai-ichi Life Insurance Company increased its Idexx Laboratories (IDXX) stake by 16% in Q1 2026, buying an estimated $321K and bringing the position to 3,645 shares worth $2.05M. The position accounts for 0.06% of the portfolio, ranked #247.
Dai-ichi Life Insurance Company first reported a position in IDXX in Q4 2016 and has held it in 37 quarters since. The position peaked at $22.2M in Q1 2019. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Dai-ichi Life Insurance Company held 3,645 shares of Idexx Laboratories worth $2.05M as of Q1 2026.
- Dai-ichi Life Insurance Company bought 500 Idexx Laboratories shares in Q1 2026, an estimated $321K.
- Idexx Laboratories made up 0.06% of Dai-ichi Life Insurance Company's portfolio in Q1 2026, its #247 holding.
- Dai-ichi Life Insurance Company first reported a position in Idexx Laboratories in Q4 2016 and has held it in 37 quarters since.
- Dai-ichi Life Insurance Company's Idexx Laboratories position peaked at $22.2M in Q1 2019.
- 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Dai-ichi Life Insurance Company's 13F filing for Q1 2026, filed 14 May 2026.